Variables

Results:

Mean (+/− SD) or %.

Mean disease duration (months)

76.49 (+/− 87.2)

Mean diagnostic delay (months)

38.27 (+/− 78.2)

Number of painful joints

5.6 (+/− 7.9)

Number of swollen joints

5.02 (+/− 5.4)

Clinical tenosynovitis (%)

27.7%

Number of night awakening

0.86 (+/− 1.8)

Morning stiffness duration (minutes)

30.4 (+/− 37.7)

Joints deformities (%)

66 %

DAS 28 CRP (mean value)

3.8 (+/− 1.2)

Extra-articulaire manifestations (%)

64%

Positivity of Rheumatoid Factor

20/30 (66.6%)

Positivity of anti-CCP

29/30 (96.6%)

Prednisone

98%

Methotrexate

70%

Sulfasalazine

28%

Hydroxychloroquine

50%

Patients followed by up to 1 DMARD

34%